This is a multi-center evaluation of NGM621 in a randomized, double-masked, sham-controlled study in participants with Geographic Atrophy secondary to Age-related Macular Degeneration.
Age: 55 years - 66+
Gender: All
We've found 1 total result for "Geographic Atrophy".